Amicogen Inc (092040) - Total Liabilities

Latest as of March 2026: ₩80.33 Billion KRW ≈ $54.44 Million USD

Based on the latest financial reports, Amicogen Inc (092040) has total liabilities worth ₩80.33 Billion KRW (≈ $54.44 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Amicogen Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Amicogen Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Amicogen Inc to evaluate short-term liquidity relative to the company's equity base.

Amicogen Inc Competitors by Total Liabilities

The table below lists competitors of Amicogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Primotec Group Ltd TA:PRMG	Israel	ILA93.97 Million
PEDEVCO Corp NYSE MKT:PED	USA	$20.52 Million
Donkeyrepublic Holding AS CO:DONKEY	Denmark	Dkr97.34 Million
SMAIO SA PA:ALSMA	France	€8.10 Million
Dongbang Agro KO:007590	Korea	₩98.77 Billion
Adveritas Ltd AU:AV1	Australia	AU$5.90 Million
Kuk Dong KO:005320	Korea	₩59.57 Billion
Atakule Gayrimenkul Yatirim Ortakligi AS IS:AGYO	Turkey	TL17.91 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Amicogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 092040 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amicogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amicogen Inc (2014–2025)

The table below shows the annual total liabilities of Amicogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩136.00 Billion ≈ $92.17 Million	-20.80%
2024-12-31	₩171.73 Billion ≈ $116.38 Million	-30.79%
2023-12-31	₩248.12 Billion ≈ $168.15 Million	-16.70%
2022-12-31	₩297.86 Billion ≈ $201.85 Million	+32.34%
2021-12-31	₩225.06 Billion ≈ $152.52 Million	+72.56%
2020-12-31	₩130.43 Billion ≈ $88.39 Million	+9.28%
2019-12-31	₩119.35 Billion ≈ $80.88 Million	+14.84%
2018-12-31	₩103.93 Billion ≈ $70.43 Million	+39.83%
2017-12-31	₩74.32 Billion ≈ $50.37 Million	+14.71%
2016-12-31	₩64.79 Billion ≈ $43.91 Million	-16.65%
2015-12-31	₩77.74 Billion ≈ $52.68 Million	+1688.10%
2014-12-31	₩4.35 Billion ≈ $2.95 Million	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$49.10 Million

₩72.45 Billion KRW

Market Cap Rank

#22015 Global

#1339 in Korea

Share Price

₩1311.00

Change (1 day)

-0.98%

52-Week Range

₩1175.00 - ₩4240.00

All Time High

₩22094.22